2695
antibody from Cell Signaling Technology, Inc
Targeting: IKBKG
FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 2695 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#2695, RRID:AB_2124826
- Product name
- IKKγ (DA10-12) Mouse mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Rat
- Host
- Mouse
- Storage
- -20°C
Submitted references p47 negatively regulates IKK activation by inducing the lysosomal degradation of polyubiquitinated NEMO.
NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling.
Shibata Y, Oyama M, Kozuka-Hata H, Han X, Tanaka Y, Gohda J, Inoue J
Nature communications 2012;3:1061
Nature communications 2012;3:1061
NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.
Biton S, Ashkenazi A
Cell 2011 Apr 1;145(1):92-103
Cell 2011 Apr 1;145(1):92-103
Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling.
Iha H, Kibler KV, Yedavalli VR, Peloponese JM, Haller K, Miyazato A, Kasai T, Jeang KT
Oncogene 2003 Dec 4;22(55):8912-23
Oncogene 2003 Dec 4;22(55):8912-23
No comments: Submit comment
No validations: Submit validation data